Breast cancer patients were then grouped into the high- and low-CRIM1 expression groups and their correlation with age, menopause, TNM stage, histological type, pathologic stage, HER2 status, and radiotherapy were investigated. This evidence concerns the gene ERBB2 and breast cancer.